MacroGenics to Participate in Two Upcoming Investor Conferences

Go back to MacroGenics to Participate in Two Upcoming Investor Conferences

MacroGenics (MGNX) PT Lowered to $42 at Stifel; Reiterates Buy

March 1, 2017 9:03 AM EST

Stifel lowered its price target on MacroGenics (NASDAQ: MGNX) to $42.00 (from $51.00) while maintaining a Buy rating.

Analyst Stephen Willey commented, "Managements relatively quiet 4Q16 earnings announcement/call was expected following the comprehensive pipeline update provided at the December 2016 R&D Day. The... More